Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KTH Holding is the investment arm of the KTH Royal Institute of Technology in Stockholm, Sweden, dedicated to commercializing university-based research. The company provides seed capital and business development support to early-stage startups and spin-offs, with a heavy emphasis on the life sciences, biotechnology, and medical technology sectors. By bridging the gap between academic innovation and the global market, KTH Holding helps transform cutting-edge scientific discoveries into viable commercial products. Its portfolio includes a diverse range of high-tech companies, many of which focus on healthcare, industrial biotechnology, and diagnostic tools. The organization works in tandem with KTH Innovation to identify high-potential research and facilitate the creation of new enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KTH Holding.